Michel Vounatsos

2018

In 2018, Michel Vounatsos earned a total compensation of $16.2M as Chief Executive Officer at Biogen, a 18% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$80,663
Non-Equity Incentive Plan$3,337,880
Salary$1,276,923
Stock Awards$11,064,897
Other$408,283
Total$16,168,646

Vounatsos received $11.1M in stock awards, accounting for 68% of the total pay in 2018.

Vounatsos also received $80.7K of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $1.3M in salary and $408.3K in other compensation.

Rankings

In 2018, Michel Vounatsos' compensation ranked 272nd out of 14,244 executives tracked by ExecPay. In other words, Vounatsos earned more than 98.1% of executives.

ClassificationRankingPercentile
All
272
out of 14,244
98th
Division
Manufacturing
92
out of 5,765
98th
Major group
Chemicals And Allied Products
30
out of 2,128
99th
Industry group
Drugs
25
out of 1,817
99th
Industry
Biological Products, Except Diagnostic Substances
7
out of 339
98th

Pay ratio

Michel Vounatsos' Pay$16,168,646
Median Employee's Pay$170,521
Pay Ratio

95

to 1

In 2018, the annual total compensation of Michel Vounatsos was $16,168,646.

The annual total compensation of the median employee at Biogen was $170,521.

The ratio of Michel Vounatsos' pay to the pay of median employee was therefore 95 to one.

Source: SEC filing on April 30, 2019.

Vounatsos' colleagues

We found four more compensation records of executives who worked with Michel Vounatsos at Biogen in 2018.

2018

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2018

Susan Alexander

Biogen

Chief Legal Officer

2018

Paul McKenzie

Biogen

Executive Vice President, Pharmaceutical Operations & Technology

2018

Jeffrey Capello

Biogen

Chief Financial Officer

News

You may also like